These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The allosteric enhancer PD81,723 increases chimaeric A1/A2A adenosine receptor coupling with Gs. Bhattacharya S, Youkey RL, Ghartey K, Leonard M, Linden J, Tucker AL. Biochem J; 2006 May 15; 396(1):139-46. PubMed ID: 16390330 [Abstract] [Full Text] [Related]
3. Thermodynamics of full agonist, partial agonist, and antagonist binding to wild-type and mutant adenosine A1 receptors. Dalpiaz A, Townsend-Nicholson A, Beukers MW, Schofield PR, IJzerman AP. Biochem Pharmacol; 1998 Dec 01; 56(11):1437-45. PubMed ID: 9827575 [Abstract] [Full Text] [Related]
4. Agonist-independent effect of an allosteric enhancer of the A1 adenosine receptor in CHO cells stably expressing the recombinant human A1 receptor. Kollias-Baker CA, Ruble J, Jacobson M, Harrison JK, Ozeck M, Shryock JC, Belardinelli L. J Pharmacol Exp Ther; 1997 May 01; 281(2):761-8. PubMed ID: 9152383 [Abstract] [Full Text] [Related]
6. Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A1 receptors of LUF5831, a novel nonadenosine-like agonist. Heitman LH, Mulder-Krieger T, Spanjersberg RF, von Frijtag Drabbe Künzel JK, Dalpiaz A, IJzerman AP. Br J Pharmacol; 2006 Mar 01; 147(5):533-41. PubMed ID: 16444290 [Abstract] [Full Text] [Related]
7. Differential allosteric modulation by amiloride analogues of agonist and antagonist binding at A(1) and A(3) adenosine receptors. Gao ZG, Melman N, Erdmann A, Kim SG, Müller CE, IJzerman AP, Jacobson KA. Biochem Pharmacol; 2003 Feb 15; 65(4):525-34. PubMed ID: 12566079 [Abstract] [Full Text] [Related]
9. Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor. Baraldi PG, Romagnoli R, Pavani MG, Nuñez Mdel C, Tabrizi MA, Shryock JC, Leung E, Moorman AR, Uluoglu C, Iannotta V, Merighi S, Borea PA. J Med Chem; 2003 Feb 27; 46(5):794-809. PubMed ID: 12593659 [Abstract] [Full Text] [Related]
10. Effects of the adenosine A1 receptor allosteric modulators PD 81,723 and LUF 5484 on the striatal acetylcholine release. Bueters TJ, van Helden HP, Danhof M, IJzerman AP. Eur J Pharmacol; 2002 Nov 15; 454(2-3):177-82. PubMed ID: 12421644 [Abstract] [Full Text] [Related]
11. An allosteric modulator of the adenosine A1 receptor potentiates the antilipolytic effect in rat adipose tissue. Fu K, Chen W, Meng M, Zhao H, Yuan H, Wang Y, Ren Y, Yun Y, Guo D. Eur J Pharmacol; 2023 Jul 15; 951():175777. PubMed ID: 37182594 [Abstract] [Full Text] [Related]
12. A "locked-on," constitutively active mutant of the adenosine A1 receptor. de Ligt RA, Rivkees SA, Lorenzen A, Leurs R, IJzerman AP. Eur J Pharmacol; 2005 Mar 07; 510(1-2):1-8. PubMed ID: 15740718 [Abstract] [Full Text] [Related]
14. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex. Alexander SP, Curtis AR, Kendall DA, Hill SJ. Br J Pharmacol; 1994 Dec 07; 113(4):1501-7. PubMed ID: 7889308 [Abstract] [Full Text] [Related]
15. Effects of long-term treatment with the allosteric enhancer, PD81,723, on Chinese hamster ovary cells expressing recombinant human A1 adenosine receptors. Bhattacharya S, Linden J. Mol Pharmacol; 1996 Jul 07; 50(1):104-11. PubMed ID: 8700102 [Abstract] [Full Text] [Related]
16. Site-directed mutagenesis studies of human A(2A) adenosine receptors: involvement of glu(13) and his(278) in ligand binding and sodium modulation. Gao ZG, Jiang Q, Jacobson KA, Ijzerman AP. Biochem Pharmacol; 2000 Sep 01; 60(5):661-8. PubMed ID: 10927024 [Abstract] [Full Text] [Related]
17. Adenosine A1 receptor-dependent and -independent effects of the allosteric enhancer PD 81,723. Musser B, Mudumbi RV, Liu J, Olson RD, Vestal RE. J Pharmacol Exp Ther; 1999 Feb 01; 288(2):446-54. PubMed ID: 9918544 [Abstract] [Full Text] [Related]
18. Site-directed mutagenesis of the human A1 adenosine receptor: influences of acidic and hydroxy residues in the first four transmembrane domains on ligand binding. Barbhaiya H, McClain R, Ijzerman A, Rivkees SA. Mol Pharmacol; 1996 Dec 01; 50(6):1635-42. PubMed ID: 8967987 [Abstract] [Full Text] [Related]
19. The effects of saponin on the binding and functional properties of the human adenosine A1 receptor. Cohen FR, Lazareno S, Birdsall NJ. Br J Pharmacol; 1996 Apr 01; 117(7):1521-9. PubMed ID: 8730749 [Abstract] [Full Text] [Related]